Nektar Therapeutics
Closed
68.49 -2.38
Overview
Share price change
24h
Min
69.1
Max
70.52
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.78 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -18M -37M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +119.34% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | -460M 2.5B |
|---|---|
Previous open | 70.87 |
Previous close | 68.49 |
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
119.34% upside
12 Months Forecast
Average 154.33 USD 119.34%
High 192 USD
Low 80 USD
Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$